Hidetsugu Tsubouchi (H Tsubouchi)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Atopic Dermatitis

Top Venues

Dermatology and therapy

The Journal of dermatology

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Hidehisa Saeki, Yukihiro Ohya, Naoko Baba, Tomomi Imamura, Daisuke Yokota, Hidetsugu Tsubouchi
An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis. Dermatology and therapy (2024)
Hidehisa Saeki, Tomomi Imamura, Daisuke Yokota, Hidetsugu Tsubouchi
Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study. Dermatology and therapy 12 (7) (2022)
H Saeki, N Baba, K Ito, D Yokota, Hidetsugu Tsubouchi
Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial. The British journal of dermatology (2021)
Hidehisa Saeki, Makoto Kawashima, Satoko Sugaya, Kazuhide Oshiden, Hidetsugu Tsubouchi
Efficacy and safety of topical OPA-15406, a new phosphodiesterase 4 inhibitor, in Japanese patients with atopic dermatitis for 8 weeks: A phase 2, randomized, double-blind, placebo-controlled study. The Journal of dermatology 46 (8) (2019)
Hidehisa Saeki, Naoko Baba, Kazuhide Oshiden, Yuji Abe, Hidetsugu Tsubouchi
Phase 2, randomized, double-blind, placebo-controlled, 4-week study to evaluate the safety and efficacy of OPA- 15406 (difamilast), a new topical selective phosphodiesterase type-4 inhibitor, in Japanese pediatric patients aged 2-14 years with atopic dermatitis. The Journal of dermatology 47 (1) (2019)